Skip to content
2000
Volume 28, Issue 9
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Background: To investigate the effects of the Lenvatinib@H-MnO-FA administration system on the proliferation and apoptosis of Intrahepatic cholangiocarcinoma (ICC) and the underlying molecular mechanism. Materials and Methods: In this research, hollow MnO (H-MnO) was synthesized via the modified Stöber method, and H-MnO was modified with polyethylene glycol-bis (Amine) (NH2-PEG-NH) and folic acid (FA) to obtain H-MnO-PEG-FA (H-MnO-FA). Lenvatinib was coated in the hollow cavity of H-MnO-PEG-FA to further form a nanometre drug-carrying system (Lenvatinib@H-MnO-PEG-FA). Lenvatinib@H-MnO-FA was characterized through transmission electron microscopy (TEM) and scanning electron microscopy (SEM). Fourier transform infrared spectroscopy (FT-IR) was used to verify that Lenvatinib was loaded on nanoparticles. Functionally, confocal laser scanning microscopy (CLSM), 2-(4-Amidinophenyl)-6-indolecarbamidine dihydrochloride (DAPI) staining, and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay were performed to determine the effect of Lenvatinib@H-MnO-FA on the proliferation and apoptosis of ICC cells (9810 cells). Finally, the protein levels of Raf-1MEK1/2-ERK1/2 signalling pathway components were detected through Western blotting analysis. Results: We successfully synthesised a Lenvatinib@H-MnO-PEG-FA administration system. The resulting nanomaterials had excellent biological stability and improved targeting effects. Functionally, Lenvatinib@ H-MnO-FA inhibited the proliferation of 9810 cells. The Bcl-2 protein level was significantly downregulated, and the caspase-3 protein level was significantly upregulated, indicating that Lenvatinib@H-MnO- PEG- FA promoted the apoptosis of 9810 cells. Mechanistically, Lenvatinib@H-MnO-FA increased the phosphorylation levels of Raf, MEK1/2, and ERK1/2. Conclusion: H-MnO-FA can more effectively deliver Lenvatinib to inhibit proliferation and promote apoptosis in ICC, which could be the promising drug delivery nano-vehicles for delivery drugs.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/1381612828666220113161712
2022-03-01
2025-04-16
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/1381612828666220113161712
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test